Galantamine (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Galantamine drug offered from Teva Pharmaceuticals USA, Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Galantamine |
SUBSTANCE NAME: | GALANTAMINE HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2008-10-15 |
END MARKETING DATE: | 2018-05-31 |
Galantamine HUMAN PRESCRIPTION DRUG Details:
Item Description | Galantamine from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 16(mg/1) |
START MARKETING DATE: | 2008-10-15 |
END MARKETING DATE: | 2018-05-31 |
PRODUCT ID: | 0555-1021_86a1c2ed-fde6-483a-802f-386cb134ad40 |
PRODUCT NDC: | 0555-1021 |
APPLICATION NUMBER: | ANDA078189 |
Other GALANTAMINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: